Titan Capital Expenditures from 2010 to 2025
| TTNP Stock | USD 3.48 0.37 9.61% |
Capital Expenditures | First Reported 1996-03-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 163.3 K |
Check Titan Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Titan Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 95.8 K, Interest Expense of 31.7 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 36.84, Dividend Yield of 0.0015 or PTB Ratio of 1.14. Titan financial statements analysis is a perfect complement when working with Titan Pharmaceuticals Valuation or Volatility modules.
Titan | Capital Expenditures |
Latest Titan Pharmaceuticals' Capital Expenditures Growth Pattern
Below is the plot of the Capital Expenditures of Titan Pharmaceuticals over the last few years. Capital Expenditures are funds used by Titan Pharmaceuticals to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Titan Pharmaceuticals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software. It is Titan Pharmaceuticals' Capital Expenditures historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Titan Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Capital Expenditures | 10 Years Trend |
|
Capital Expenditures |
| Timeline |
Titan Capital Expenditures Regression Statistics
| Arithmetic Mean | 215,125 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 139.80 | |
| Mean Deviation | 203,656 | |
| Median | 171,000 | |
| Standard Deviation | 300,741 | |
| Sample Variance | 90.4B | |
| Range | 1.2M | |
| R-Value | (0.37) | |
| Mean Square Error | 83.4B | |
| R-Squared | 0.14 | |
| Significance | 0.15 | |
| Slope | (23,582) | |
| Total Sum of Squares | 1.4T |
Titan Capital Expenditures History
About Titan Pharmaceuticals Financial Statements
Titan Pharmaceuticals shareholders use historical fundamental indicators, such as Capital Expenditures, to determine how well the company is positioned to perform in the future. Although Titan Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Titan Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Titan Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year |
Additional Tools for Titan Stock Analysis
When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.